Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urban Novak

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
A&A Practice|July 28, 2018
Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent ProblemKaspar F Bachmann, Mathias Nebiker, Caroline Johner, et al.
Cancers|July 27, 2022
Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell TherapySimona Gössi, Ulrike Bacher, Claudia Haslebacher, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Biomolecules|February 25, 2023
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment OutcomeTim Lakomy, Dilara Akhoundova, Henning Nilius, et al.
Cancers|December 10, 2021
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL PatientsAnna Nydegger, Urban Novak, Marie-Noëlle Kronig, et al.
Systematic Reviews|February 14, 2014
HHV-8 seroprevalence: a global viewEliane Rohner, Natascha Wyss, Sven Trelle, et al.
Hemasphere|November 15, 2019
Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML PatientsBianca R Schnell, Katja Seipel, Ulrike Bacher, et al.
BMJ Open|May 25, 2022
Characteristics and survival of patients with cancer with intended off-label use-a cohort studyAndreas Michael Schmitt, Martin Walter, Amanda Katherina Herbrand, et al.
Leukemia & Lymphoma|September 14, 2004
P73 status in B-cell chronic lymphocytic leukaemiaNicolas Leupin, Alexander Lüthi, Urban Novak, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
A&A Practice|July 28, 2018
Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent ProblemKaspar F Bachmann, Mathias Nebiker, Caroline Johner, et al.
Cancers|July 27, 2022
Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell TherapySimona Gössi, Ulrike Bacher, Claudia Haslebacher, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Biomolecules|February 25, 2023
Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment OutcomeTim Lakomy, Dilara Akhoundova, Henning Nilius, et al.
Cancers|December 10, 2021
Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL PatientsAnna Nydegger, Urban Novak, Marie-Noëlle Kronig, et al.
Systematic Reviews|February 14, 2014
HHV-8 seroprevalence: a global viewEliane Rohner, Natascha Wyss, Sven Trelle, et al.
Hemasphere|November 15, 2019
Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML PatientsBianca R Schnell, Katja Seipel, Ulrike Bacher, et al.
BMJ Open|May 25, 2022
Characteristics and survival of patients with cancer with intended off-label use-a cohort studyAndreas Michael Schmitt, Martin Walter, Amanda Katherina Herbrand, et al.
Leukemia & Lymphoma|September 14, 2004
P73 status in B-cell chronic lymphocytic leukaemiaNicolas Leupin, Alexander Lüthi, Urban Novak, et al.
Pageof 11